H.R. 1117 · 118th Congress (2023–2025)
Advancing Safe Medications for Moms and Babies Act of 2023
This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research.
For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research.
The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research.
The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.
Show official title
To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 1117’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Kathy Castor (D-FL-14)
- Cosponsors
30 cosponsors
2 original · 28 later
2 R · 28 D
- Rep. Brian K. Fitzpatrick (R-PA-1)· Original · Feb 21, 2023
- Rep. Lauren Underwood (D-IL-14)· Original · Feb 21, 2023
- Rep. Suzan K. DelBene (D-WA-1)· Later · Mar 9, 2023
- Rep. Ann M. Kuster (D-NH-2)· Later · Mar 9, 2023
- Rep. Joseph D. Morelle (D-NY-25)· Later · Mar 9, 2023
- Rep. Wiley Nickel (D-NC-13)· Later · Mar 9, 2023
- Rep. Chris Pappas (D-NH-1)· Later · Mar 9, 2023
- Rep. Rashida Tlaib (D-MI-12)· Later · Mar 9, 2023
- Rep. Susan Wild (D-PA-7)· Later · Mar 9, 2023
- Rep. Lisa Blunt Rochester (D-DE)· Later · Apr 6, 2023
- Rep. Sean Casten (D-IL-6)· Later · Apr 6, 2023
- Rep. Sharice Davids (D-KS-3)· Later · Apr 6, 2023
- Rep. Robert Menendez (D-NJ-8)· Later · Apr 13, 2023
- Rep. Yadira Caraveo (D-CO-8)· Later · May 15, 2023
- Rep. Josh Gottheimer (D-NJ-5)· Later · May 15, 2023
- Rep. Mary Sattler Peltola (D-AK)· Later · May 15, 2023
- Rep. Robin L. Kelly (D-IL-2)· Later · May 31, 2023
- Rep. Stephen F. Lynch (D-MA-8)· Later · Jul 6, 2023
- Rep. Daniel S. Goldman (D-NY-10)· Later · Aug 29, 2023
- Rep. Mark Pocan (D-WI-2)· Later · Aug 29, 2023
- Rep. Colin Z. Allred (D-TX-32)· Later · Sep 20, 2023
- Rep. Kathy E. Manning (D-NC-6)· Later · Sep 20, 2023
- Rep. Jerrold Nadler (D-NY-12)· Later · Sep 20, 2023
- Rep. Chellie Pingree (D-ME-1)· Later · Sep 20, 2023
- Rep. Terri A. Sewell (D-AL-7)· Later · Oct 24, 2023
- Rep. Angie Craig (D-MN-2)· Later · Nov 28, 2023
- Rep. Scott H. Peters (D-CA-50)· Later · Nov 28, 2023
- Rep. Lois Frankel (D-FL-22)· Later · Jan 10, 2024
- Rep. Alma S. Adams (D-NC-12)· Later · Feb 28, 2024
- Rep. Don Bacon (R-NE-2)· Later · Apr 10, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Feb 21, 2023 – Mar 3, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Advancing Safe Medications for Moms and Babies Act of 2023
Display title, Short title · Introduced in House
To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.
Official title · Introduced in House